Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Yolanda Mira"'
Autor:
Silvia Navarro, Pilar Medina, Yolanda Mira, Amparo Estellés, Piedad Villa, Fernando Ferrando, Amparo Vayá, Rogier M. Bertina, Francisco España
Publikováno v:
Haematologica, Vol 93, Iss 6 (2008)
Background Haplotypes A1 and A3 in the endothelial protein C receptor (EPCR) gene are tagged by 4678G/C and 4600A/G respectively. We assessed whether these haplotypes modify the risk of venous thromboembolism in carriers of the prothrombin 20210A all
Externí odkaz:
https://doaj.org/article/f6338203ec7d42e5989dd03161821ae7
Autor:
Yolanda Mira, Artur Oliver, Meritxell López, Edelmira Martí, María C Sabater, Ana María Rodríguez, Carmen Medina, Reyes Aguinaco, Mariana Stevenazzi, Amparo Santamaría, Ana Margarita Redondo
Publikováno v:
Journal of Blood & Lymph. 9
Aim: In placenta-mediated pregnancy complications, evidence-based guidelines are based on studies with controversial results or expert opinion. In this context, the implementation of those guidelines is quite different among physicians. Our aim was t
Publikováno v:
Thrombosis and Haemostasis. 103:1091-1101
SummaryMost computer- or internet-assisted systems for oral anticoagulation therapy (OAT) telemanagement have limitations when it comes to implementation within a healthcare center. It was the objective of this study to evaluate convenience and patie
Autor:
Pilar Medina, Francisco España, Amparo Estellés, Amparo Vayá, Silvia Navarro, Fernando Ferrando, Piedad Villa, Rogier M. Bertina, Yolanda Mira
Publikováno v:
Haematologica. 93:885-891
Haplotypes A1 and A3 in the endothelial protein C receptor (EPCR) gene are tagged by 4678G/C and 4600A/G respectively. We assessed whether these haplotypes modify the risk of venous thromboembolism in carriers of the prothrombin 20210A allele.We geno
Autor:
Fernando Ferrando, Yolanda Mira
Publikováno v:
Interactive Journal of Medical Research
Interactive Journal of Medical Research, Vol 4, Iss 2, p e10 (2015)
Interactive Journal of Medical Research, Vol 4, Iss 2, p e10 (2015)
BackgroundDespite the existing evidence that highlights the benefits of oral anticoagulation therapy (OAT) self-testing and self-management by patients in comparison with conventional control, significant progress is still needed in the implementatio
Autor:
Piedad Villa, Justo Aznar, Francisco España, Amparo Estellés, Silvia Navarro, Pilar Medina, Amparo Vayá, Rogier M. Bertina, Fernando Ferrando, Barry Woodhams, Yolanda Mira, Martine Migaud-Fressart
Publikováno v:
Thrombosis and Haemostasis. 91:905-911
SummaryEndothelial cell protein C receptor (EPCR) enhances the generation of activated protein C (APC) by the thrombin-thrombomodulin complex. A soluble form of EPCR (sEPCR), which is generated by metalloprotease activity, is present in plasma. The d
Autor:
Justo Aznar, Piedad Villa, Dolores Corella, Amparo Estellés, Fernando Ferrando, Yolanda Mira, Amparo Vayá
Publikováno v:
Thrombosis and Haemostasis. 91:1031-1034
SummaryThe association between factor V Leiden (FVL) and prothrombin G20210A (PT 20210) mutations and ischemic stroke remains controversial, particularly in young adults with cryptogenic stroke. Prevalence of FVL (4.1%) and PT 20210 (8.2%) mutations
Autor:
Amparo Vayá, Justo Aznar, Amparo Estellés, Fernando Ferrando, Yolanda Mira, MaTeresa Contreras, Francisco España, Dolores Corella
Publikováno v:
British Journal of Haematology. 118:255-259
Summary. To ascertain the potential contribution of serum lipids to the development of deep vein thrombosis (DVT), a case–control study was conducted in 143 DVT patients lacking thrombophilic risk factors and in 194 age- and sex-matched controls. D
Autor:
Justo Aznar, Amparo Vayá, Piedad Villa, Fernando Ferrando, Yolanda Mira, Milagros Garcı́a, Amparo Estellés
Publikováno v:
Thrombosis Research. 104:293-296
Homozygous 20210G/A Prothrombin Gene Mutation Associated with Bilateral Iliac Vein Thrombosis: A Case Report Amparo Vaya, Milagros Garcia, Yolanda Mira, Fernando Ferrando, Piedad Villa, Amparo Estelles and Justo Aznar Thrombosis and Hemostasis Unit,
Autor:
Yolanda Mira, Piedad Villa, José Todolí, Amparo Estellés, Justo Aznar, Amparo Vayá, Ma Luisa Micó, Rosario Alonso, Fernando Ferrando
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 7:234-237
The factor V Leiden (FV Leiden) and prothrombin G20210A mutations, are the most common established genetic risk factors for deep vein thrombosis (DVT). However, the relationship. between these mutations and arterial thrombotic syndromes (coronary hea